A functional polymorphism in the SCN1A gene is not associated with carbamazepine dosages in Austrian patients with epilepsy.
Fritz
F
Zimprich
Elisabeth
E
Stogmann
Silvia
S
Bonelli
Christoph
C
Baumgartner
Jakob C
JC
Mueller
Thomas
T
Meitinger
Alexander
A
Zimprich
Tim M
TM
Strom
D000927:Anticonvulsants / Q000008:administration & dosage*; D001317:Austria; D002220:Carbamazepine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D004827:Epilepsy / Q000188:drug therapy* / Q000235:genetics*; D005838:Genotype; D006801:Humans; D062550:NAV1.1 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D015203:Reproducibility of Results; D015222:Sodium Channels / Q000235:genetics*
D000927:Anticonvulsants; D062550:NAV1.1 Voltage-Gated Sodium Channel; D009419:Nerve Tissue Proteins; C568242:SCN1A protein, human; D015222:Sodium Channels; D002220:Carbamazepine